• Nitrocefin: Chromogenic Cephalosporin Substrate for Preci...

  2025-10-23

  Nitrocefin enables rapid, colorimetric β-lactamase detection and antibiotic resistance profiling in clinical and research laboratories. Its robust chromogenic response streamlines workflows for studying resistance mechanisms and screening β-lactamase inhibitors, especially in emerging multidrug-resistant pathogens.

• Charting New Frontiers in β-Lactamase Resistance: Mechani...

  2025-10-22

  This thought-leadership article explores the escalating crisis of β-lactam antibiotic resistance, delves into the molecular and experimental foundations of β-lactamase detection, and delivers a strategic roadmap for translational researchers. Integrating recent mechanistic discoveries—such as the GOB-38 MBL variant in Elizabethkingia anophelis—with advanced assay strategies, we spotlight Nitrocefin as a pivotal chromogenic cephalosporin substrate for resistance profiling and inhibitor screening. The discussion transcends standard product narratives, providing actionable guidance for next-generation resistance mapping and translational innovation.

• Bedaquiline: Transforming Tuberculosis and Cancer Stem Ce...

  2025-10-21

  Bedaquiline stands at the forefront as a diarylquinoline antibiotic, offering unmatched potency against multi-drug resistant tuberculosis and cancer stem cells. This guide delivers actionable workflows, comparative advantages, and troubleshooting strategies to maximize research impact in infectious disease and oncology.

• Bedaquiline: Scientific Frontiers in Host-Pathway Modulation

  2025-10-20

  Explore how Bedaquiline, a diarylquinoline antibiotic and Mycobacterium tuberculosis F1FO-ATP synthase inhibitor, is redefining multi-drug resistant tuberculosis treatment and cancer research through advanced host-pathway modulation. This in-depth analysis unveils novel therapeutic strategies and mechanistic insights distinct from existing research guides.

• Bedaquiline: Revolutionizing Drug-Resistant Tuberculosis ...

  2025-10-19

  Bedaquiline stands apart as a diarylquinoline antibiotic, uniquely targeting Mycobacterium tuberculosis F1FO-ATP synthase and inhibiting cancer stem cell metabolism. This guide delivers optimized workflows, advanced troubleshooting, and translational insights for researchers combating multi-drug resistant tuberculosis and cancer stem cell expansion.

• Cisapride (R 51619): Deep Phenotyping Tools for Cardiac a...

  2025-10-18

  Explore how Cisapride (R 51619), a nonselective 5-HT4 receptor agonist, powers next-generation research in 5-HT4 signaling and hERG channel inhibition. This article uniquely examines its integration with iPSC-derived models and deep learning for advanced cardiac and gastrointestinal studies.

171 records 12/12 page Previous First page 上5页 1112